Trump Orders Expanded Access to Certain Psychedelic Substances

US President Donald Trump has issued an executive order to expand access to certain psychedelic substances, including LSD, psilocybin, and ibogaine. The order aims to accelerate research on the potential therapeutic benefits of these substances for mental health disorders.

The executive order was signed into law by Trump in a meeting with Joe Rogan, a popular podcast host and advocate for psychedelics. The order includes provisions for expedited review of psychedelic substances for medical use, as well as increased funding for research into their potential therapeutic applications.

According to reports, the order also includes language that allows the US government to reclassify certain psychedelic substances, potentially making them more accessible for research and treatment purposes.

The executive order is part of a broader effort by Trump’s administration to explore the potential benefits of psychedelics for mental health. The move has been met with interest from researchers and advocates in the field, who see it as an opportunity to advance the study of these substances.

Details of the executive order have not been made public, but reports suggest that it includes provisions for increased funding for research into psychedelic substances, as well as guidelines for expedited review of potential therapeutic applications.

Source: Google News World